Diabetes is a state of chronic hyperglycemia linked to absolute or relative insulin deficiency, in relation to genetic and/or environmental factors often acting in concert [1] . It is a truly global pandemic. According to the International Diabetes Federation (IDF), an estimated 366.2 million adults worldwide have diabetes. Of these, 14.7 million live in Africa. IDF experts predict that 552 million adults will have diabetes by 2030 [2] . In Africa, the prevalence of diabetes is on the rise. Africa has the highest proportion of undiagnosed diabetes, estimated at at least 78% [2] . In Senegal, prevalence data remain approximate. According to the results of the 2015 IDF WHO STEPS national survey, 3.24% of the Senegalese population are thought to be diabetic [3] . Diabetes is a condition that predisposes to the occurrence of numerous complications, notably cardiovascular. Classically, there are two groups of cardiovascular complications: microangiopathy and macroangiopathy, with lesions of the large vessels responsible for myocardial infarction, stroke and ischemia of the lower limbs. These macroangiopathic complications are distinguished in diabetics by their severity, and can evolve on their own account.

Macrovascular complications are the main cause of morbidity and mortality in patients with type 2 diabetes. In the first ten years after diagnosis of type 2 diabetes, complications of macro angiopathy predominate [4] [5] . Among diabetes-related complications, cardiovascular events remain the most formidable. They are the leading cause of mortality in diabetics. In Saint Louis, stroke occurred in 2% of diabetics and coronary heart disease in 12.2% [6] . In fact, around one in two diabetic patients dies of cardiovascular disease [7] [8] .

In the USA, 77% of hospitalizations for cardiovascular disease are attributable to diabetes [9] . In a study carried out at the Fann Hospital, the association between diabetes and cardiovascular disease was 9.2% [10] . Arteriopathy of the lower limbs is a classic complication of diabetes that can lead to amputation.

In view of the high prevalence of diabetic macroangiopathy (DMA), we thought it would be interesting to take stock of macroangiopathic complications in diabetic patients in the internal medicine department of the Abass Ndao Hospital. The general objective was to describe the epidemiological, clinical, paraclinical, therapeutic and evolutionary characteristics of our patients.

The study was carried out in the internal medicine department of the Abass Ndao Hospital in Dakar. It was a descriptive and analytical cross-sectional study of diabetic subjects hospitalized for diabetic macroangiopathy. Our patients were recruited over a 7-year period (January 01, 2016 to December 31, 2022). The DAM was stroke, AOMI and/or coronary artery disease.

Not included in our work:

- All diabetic patients without diabetic macroangiopathy

- Clinically and/or paraclinically incomplete files were not included in the final evaluation.

A standard questionnaire was drawn up to serve as the basis for data collection for patients included in the study. Data were collected from the charts of patients meeting the inclusion criteria.

The data collected concerned: Socio-demographic characteristics, clinical and paraclinical characteristics, study of diabetes mellitus, evolution and therapeutic aspects.

Data collection procedure

v Collection tools

A standard questionnaire was drawn up to serve as the basis for data collection for patients included in the study. It covered marital status, clinical and paraclinical manifestations, diabetic study and evolution during hospitalization.

v Sources of collettes

Data were collected from the records of patients fulfilling the inclusion criteria.

Study variables

The data collected concerned:

Socio-economic characteristics: age, gender, profession, place of origin

- Clinical characteristics: The study of diabetes mellitus focused on the type of diabetes, how long it had been present, and its glycemic control,

- Cardiovascular risk factors were also studied. These included hypertension, smoking, obesity, dyslipidemia and anemia.

Patients were considered hypertensive if systolic blood pressure was greater than or equal to 140 mmHg and/or diastolic blood pressure greater than or equal to 90 mmHg, or if blood pressure figures were normal on antihypertensive treatment [11] . Classification of hypertension was based on the WHO [11] . Dyslipidemia was defined as total hypercholesterolemia > 2 g/l, HDL hypocholesterolemia < 0.35 g/l, LDL hypercholesterolemia > 1 g/l and/or hypertriglyceridemia > 1.5 g/l, or in a patient already known and/or treated for dyslipidemia.

Diabetes typing, in the absence of immunology and C-peptide assay, was presumptive based on clinical and evolutionary arguments (patient’s age, morphotype, time to onset of symptoms, family history and evolution under treatment).

History and vitals: blood pressure, pulse, temperature, diuresis, capillary glucose, glucosuria and ketonuria.

The diagnosis of diabetic macroangiopathy was retained if the patient presented with one of the following cardiovascular conditions: stroke, coronary insufficiency and/or arteriopathy of the lower limbs. For this study, we selected all patients for whom the diagnosis of macroangiopathy was confirmed on the basis of clinical and paraclinical criteria (electrocardiogram, cardiac Doppler ultrasound, cerebral CT scan and arterial Doppler ultrasound of the lower limbs).

- Paraclinical characteristics

These included blood count, creatinine and uremia levels, CRP, HbA1C, fasting blood glucose, lipid profile, blood ionogram, electrocardiogram (ECG), cardiac Doppler ultrasound, Doppler ultrasound of the lower limbs, foot X-ray, chest X-ray and brain scan.

- Evolutionary characteristics (mean length of hospital stay, mortality) were noted.

Data capture and analysis

Data were entered using Microsoft Office Excel and then analyzed using epi info 2000 version 3.3.2 to compare two proportions.

For descriptive analysis, data were presented as percentages for qualitative variables and as averages for quantitative variables.

Ethical considerations: The hospital ethics committee approved our study.

Our study has certain limitations. Data collection was not exhaustive, due to missing data in the files. Some patients had not had all the paraclinical tests carried out, due to the high cost of these examinations.

Epidemiological aspects:

The frequency of macroangiopathy seems to vary with the recruiting department and sample size. Our result of 10.22% seems to be higher than the data from the team of Abduelkarem et al. in Libya, which was 18.8% [12] . In a recent study, Dioum et al. [10] found a frequency of 9.0% among cardiology inpatients. Donadji et al. found a much lower hospital frequency of 3.98% in Ndjamena [13] . In Senegal in 2002, Charles et al., in their study of elderly diabetics at the same center, found macro angiopathy in 30% of cases [14] .

Frequencies of 21.1% 27.6%, and 60.63% were respectively reported in Côte d’Ivoire studies by Lokrou A et al. [15] , Khanouach et al. [16] , Kouakou et al. [17] . These results are similar to those of Takogue, whose overall prevalence of subclinical macroangiopathy was 76.5% [18] . Imen Sebai’s study found 54% macroangiopathy in type 2 diabetics [19] . In our study, a slight predominance of women (50.1%) was noted, with a sex ratio (m/f) of 0.99. Other authors have also found a female predominance [10] [20] . In the study by Imen S and Cederholm et al., men were 2.9 times more likely to develop macroangiopathy than women [19] [21] . This difference is thought to be linked to the higher prevalence of male smoking and the particular estrogenic climate enjoyed by non-menopausal women. Type 2 diabetes accounted for the majority of cases in our study (95.82%). Worldwide, type 2 diabetes accounts for 90% of all cases of diabetes. These results are similar to those of Dionadji, and SOW D in Dakar with a predominance of 89.6% type 2 diabetes [13] [22] .

The mean age was 62.83 years, with extremes ranging from 17 to 98 years. Kouakou et al. in their study had an age range from 18 months to 81 years, with a mean of 54.62 years, with an average of 54.62 years [16] . Elsewhere, the average age was 57.9 ± 6.6 years [19] .

Clinical aspects:

In our study, the mean duration of diabetes was 10.3 years. A similar average was reported in the study by Abdesselem et Coll, where the mean duration of diabetes was 12.98 ± 7.3 years [12] . Inaugural diabetes was noted in 12 cases (3.34%); in the series by Komi Dzidzonu Nemi, stroke revealed diabetes in 3.8% of cases [23] . This rate is close to that of Ouédraogo et al. [24] and Djibril et al. [25] , who reported 4.8% and 6.7% strokes respectively.

In our series, the mean blood glucose level was 2.60 g/l, and blood glucose levels above 2 g/l were noted in 33.4% of patients. These results are below those found in the studies by Yessoufou and Brehima, who found 72% and 100% hyperglycemia respectively [26] [27] .

In our study, the mean HbA1c was 7.73%. In the literature, a correlation between unbalanced diabetes and the occurrence of macrovascular complications has been reported. Mitsios et al. found that an HbA1C level ≥ 6.5% was associated with a high risk of stroke in diabetic patients [28] . Dioum et al. found unbalanced diabetes with a mean glycated hemoglobin level of 8.32 ± 2.33 [10] . It is therefore necessary to raise diabetic patients’ awareness of the need to follow not only their drug treatment, but also and above all hygienic and dietary measures, in order to avoid the occurrence of vascular complications.

In the literature, macroangiopathy is associated with a number of cardiovascular factors such as arterial hypertension. [19] [29] . In our population, hypertension was found in 41.8% of cases. In Ragul B study, hypertension was present in 30.23% and was the main risk factor associated with diabetes [30] . Aidin Rawshani et al. have shown that strict control of glycemic control and cardiovascular risk factors reduces the risk of death, myocardial infarction and stroke [31] .

In our series, AOMI predominated (50%). This may be explained by the proximity of the national diabetes management center to the hospital. In Saint Louis, Ndour Mbaye found a prevalence of 14.5% [6] ; in Algeria, Belhadj et al. found 8.5% of lower limb arteriopathy [32] . In Douala Ndambwe Moussio V, the prevalence of AOMI was 15.1% [33] . In cardiology, coronary syndrome predominated [9] . The prevalence of acute coronary disease was 37.59% [9] . In our study population, 28.1% had suffered a stroke. The mean age of these patients was 65.8 years. - In Saint louis, stroke occurred in 2.0% [6] . The average hospital stay was 7.65 days, due to inpatient investigations and referral to surgery for other types of diagnostic and therapeutic investigations.

Therapeutic aspects:

In terms of therapy, antidiabetic drugs were administered to all patients. Insulin therapy was used in 54.87%. Patients were on conventional medical treatment (aspirin, statins, diuretics and antihypertensives).

Evolution:

Seventy-three patients (20.3%) died during hospitalization, compared with 12.03% and 16.4% elsewhere [10] and [13] . Stroke was the leading cause of death (24.8%), with age and cardiovascular risk factors being predictive of death.

This study shows the aspects of diabetic macroangiopathy in our practice context, and the need to strengthen prevention and management strategies for diabetics in order to reduce morbidity and mortality.

The authors declare no conflicts of interest regarding the publication of this paper.

Djiby, S., Boundia, D., Assane, N.M., Demba, D., Mouhamed, D., Mané, D.I., Ndiouga, F., Khoudia, G., Kiné, G.F., Anna, S., Nourou, D.S. and Maimouna, N.M. (2024) Diabetic Macroangioapathy at the Internal Medicine Department of the Abass Ndao Hospital Center (About 359 Cases). Journal of Diabetes Mellitus, 14, 1-12. https://doi.org/10.4236/jdm.2024.141001